Article information
Abstract
Hidradenitis suppurativa is a chronic inflammatory disease that usually affects areas of the skin with a high density of apocrine glands (axillae, groin, perianal and perineal regions, submammary area, etc). It usually appears in women during puberty. The etiology of the disease is unknown, although it is thought to be a primary defect of the hair follicle. When diagnosing hidradenitis suppurativa, a number of genetic and hormonal predisposing factors should be considered alongside other putative triggers, such as obesity, smoking, and tight clothing. Diagnosis is essentially clinical and it is important to bear in mind the possible complications associated with the disease, such as the development of tumors. Management of the disease includes general measures (antiseptic soaps, warm baths, etc), pharmacological therapy (topical, intralesional, and systemic), surgery (direct closure, second-intention healing, grafts, flaps, etc), and other measures (carbon dioxide laser, radiation therapy, etc). It is important that the disease be diagnosed and treated as soon as possible given the potential physical and psychological problems that it can generate.
Key words:
surgery
hidradenitis suppurativa
infliximab
treatment
Resumen
La hidrosadenitis supurativa (HS) es una enfermedad inflamatoria crónica que suele manifestarse en zonas cutáneas con gran densidad de glándulas apocrinas (axilas, ingles, región perianal, perineal, submamaria, etc.). Suele iniciarse en mujeres durante la pubertad. La etiología de esta enfermedad es desconocida, aunque se considera un defecto primario del folículo piloso. Debemos considerar una serie de factores predisponentes (genéticos y hormonales) y otros desencadenantes controvertidos (obesidad, tabaco, ropa ajustada, etc.) en el diagnóstico de la HS. El diagnóstico es básicamente clínico y es importante tener en cuenta las posibles complicaciones derivadas del padecimiento de esta enfermedad, como la posibilidad de desarrollar lesiones tumorales. El manejo de esta patología comprende diversas pautas: medidas generales (jabones antisépticos, baños templados, etc.), farmacológicas (tópicas, intralesionales y sistémicas), quirúrgicas (cierre directo, cierre por segunda intención, injertos, colgajos, etc.) y otras medidas (láser CO2, radioterapia, etc.). Es importante identificar y tratar cuanto antes esta patología debido a los potenciales problemas físicos y psicológicos en los que puede derivar.
Palabras clave:
cirugía
hidrosadenitis supurativa
infliximab
tratamiento
Full text is only aviable in PDF
References
[1.]
D.E.M. Slade, B.W. Powell, P.S. Mortimer.
Hidradenitis suppurativa: pathogenesis and management.
Br J Plast Surg, 56 (2003), pp. 451-461
[2.]
G.B.E. Jemec, M. Heidenheim, N.H. Nielsen.
The prevalence of hidradenitis suppurativa and its potential precursor lesions.
J Am Acad Dermatol, 35 (1996), pp. 191-194
[3.]
P. Wolkenstein, A. Loundon, K. Barrau, P. Auquier, J. Revuz.
Quality of Life Group of the French Society of Dermatology.
J Am Acad Dermatol, 56 (2007), pp. 621-623
[4.]
G.B.E. Jemec.
Body weight in hidradenitis suppurativa.
Acne and Related disorders, pp. 375-376
[5.]
J.M. Der Werth, H.C. Williams, J.A. Raeburn.
The clinical genetics of hidradenitis suppurativa revisited.
Br J Dermatol, 142 (2000), pp. 947-953
[6.]
J.H. Barth, T. Kealey.
Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa.
Br J Dermatol, 125 (1991), pp. 304-308
[7.]
A. Koning, C. Lehmann, R. Rompel, R. Happle.
Cigarette smoking as a triggering factor of hidradenitis suppurativa.
Dermatology, 198 (1999), pp. 261-264
[8.]
W.P. Morgan, G. Leicester.
The role of depilation and deodorants in hidradenitis suppurativa.
Br J Surg, 66 (1979), pp. 853-856
[9.]
A.J. Stellon, M. Wakeling.
Hidradenitis suppurativa associated with use of oral contraceptives.
Br Med J, 298 (1989), pp. 28-29
[10.]
A.K. Gupta, S.R. Knowles, M.A. Gupta, R. Jaunkalns, N.H. Shear.
Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium.
J Am Acad Dermatol, 32 (1995), pp. 382-386
[11.]
G. Plewig, A. Kligman.
Acne, morphogenesis and treatment.
Springer, (1975),
[12.]
P.S. Mortimer, P.J. Lunniss.
Hidradenitis suppurativa.
J R Soc Med, 93 (2000), pp. 420-422
[13.]
A.S. Highet, R.J. Hay, S.O.B. Roberts.
Bacterial infections.
Textbook of dermatology, 5th ed., pp. 953-1031
[14.]
H.J. Hurley.
Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurative, and familial benign pemfigus: Surgical approach.
Dermatologic surgery. Principles and practice, pp. 717-743
[15.]
J.M. Church, V.W. Fazio, I.C. Lavery, J.R. Oakley, J.W. Milsom.
The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease.
Int J Colorectal Dis, 8 (1993), pp. 117-119
[16.]
E.V. Tsianos, G.N. Dalekos, C. Tzermias, M. Merkouropoulos, J. Hatzis.
Hidradenitis suppurativa in Crohn's disease. A further support to this association.
J Clin Gastroenterol, 20 (1995), pp. 151-153
[17.]
J. Boer, E.F. Weltevreden.
Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions.
Br J Dermatol, 135 (1996), pp. 721-725
[18.]
H.J.J. Hurley.
Apocrine glands.
McGraw Hill, (1979),
[19.]
F. Tennant Jr., J.R. Bergeron, O.J. Stone, J.F. Mullins.
Anemia associated with hidradenitis suppurativa.
Arch Dermatol, 98 (1968), pp. 138-140
[20.]
S.T. Williams, R.C. Busby, R.J. DeMuth, H. Nelson.
Perineal hidradenitis suppurativa: presentation of two unusual complications and a review.
Ann Plast Surg, 26 (1991), pp. 456-462
[21.]
J. Lapins, W. Ye, O. Nyren, L. Emtestam.
Incidence of cancer among patients with hidradenitis suppurativa.
Arch Dermatol, 137 (2001), pp. 730-734
[22.]
S.L. Moschella.
Hidradenitis suppurativa. Complications resulting in death.
JAMA, 198 (1966), pp. 201-203
[23.]
F.B. Vasey, N.A. Fenske, G.B. Clement, P.H. Bridgeford, B.F. Germain, L.R. Espinoza.
Immunological studies of the arthritis of acne conglobata and hidradenitis suppurativa.
Clin Exp Rheumatol, 2 (1984), pp. 309-311
[24.]
G.B.E. Jemec, P. Wenelboe.
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.
J Am Acad Dermatol, 39 (1998), pp. 971-974
[25.]
O.J. Clemmensen.
Topical treatment of hidradenitis supurativa with clindamycin.
Int J Dermatol, 22 (1983), pp. 325-328
[26.]
J. Boer, J.P. Mirjan, V. Gemert.
Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa.
J Am Acad Dermatol, 40 (1999), pp. 73-76
[27.]
E.T.Y. Chow, P.S. Mortimer.
Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate.
Br J Dermatol, 126 (1992), pp. 415
[28.]
A.K. Banerjee.
Surgical treatment of hidradenitis suppurativa.
Br J Surg, 79 (1992), pp. 863-866
[29.]
P.S. Mortimer, R.P.R. Dawber, M.A. Gales, R.A. Moore.
A double-blind cross-over trial of cyproterone acetate in females with hidradenitis suppurativa.
Br J Dermatol, 115 (1986), pp. 263-268
[30.]
A.M. Farrell, V.A. Randall, T. Vafaee, R.P. Dawber.
Finasteride as a therapy for hidradenitis suppurativa.
Br J Dermatol, 141 (1999), pp. 1138-1139
[31.]
D.A. Buckley, S. Rogers.
Cyclosporin-responsive hidradenitis suppurativa.
J R Soc Med, 88 (1995), pp. 289-290
[32.]
G.B.E. Jemec.
Methotrexate is of limited value in the treatment of hidradenitis suppurativa.
Clin Exp Dermatol, 27 (2002), pp. 528-529
[33.]
T.P. Sullivan, E. Welsh, F.A. Kerdel, A.E. Burdick, R.S. Kirsner.
Infliximab for hidradenitis suppurativa.
Br J Dermatol, 149 (2003), pp. 1046-1049
[34.]
J. Pedraz, E. Daudén, S. Pérez-Gala, R. Goiriz-Valdés, P. Fernández-Peñas, A. García-Díez.
Hidrosadenitis supurativa tratada con infliximab.
Actas Dermosifiliogr, 98 (2007), pp. 325-331
[35.]
C. Cusack, C. Buckley.
Etanercept: effective in the management of hidradenitis suppurativa.
Br J Dermatol, 154 (2006), pp. 726-729
[36.]
M.R. Kaur, H.M. Lewis.
Hidradenitis suppurativa treated with dapsone: A case series of five patients.
J Dermatolog Treat, 17 (2006), pp. 211-213
[37.]
M.A. Vickers.
Operative management of hidradenitis suppurativa of the scrotum and perineum.
J Urol, 114 (1975), pp. 414-416
[38.]
G.B.E. Jemec.
Effect of localized surgical excisions in hidradenitis suppurativa.
J Am Acad Dermatol, 18 (1988), pp. 1103-1107
[39.]
S.C. Brown, N. Kazzazi, P.H. Lord.
Surgical treatment of perineal hidradenitis suppurativa: with special reference to recognition of the perianal form.
Br J Surg, 73 (1986), pp. 978-980
[40.]
W.P. Morgan, K.G. Harding, L.E. Hughes.
A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa.
Ann R Coll Surg Engl, 65 (1983), pp. 235-236
[41.]
E.T. Elwood, D.G. Bolitho.
Negative-pressure dressings in the treatment of hidradenitis suppurativa.
Ann Plast Surg, 46 (2001), pp. 49-51
[42.]
M.G. Soldin, P. Tulley, H. Kaplan, D.A. Hudson, A.O. Grobbelaar.
Chronic axillary hidradenitis – the efficacy of wide excision and flap coverage.
Br J Plast Surg, 53 (2000), pp. 434-436
[43.]
E.M. Finley, J.L. Ratz.
Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second intention healing.
J Am Acad Dermatol, 34 (1996), pp. 465-469
[44.]
A. Downs.
Smoothbeam laser treatment may help improve hidradenitis suppurativa but not Hailey-Hailey disease.
J Cosmet Laser Ther, 6 (2004), pp. 163-164
[45.]
D. Frohlich, D. Baaske, M. Glatzel.
Radiotherapy of hidradenitis suppurativa – still valid today?.
Strahlenther Onkol, 176 (2000), pp. 286-289
[46.]
J.L. Bong, K. Shalders, E. Saihan.
Treatment of persistent painful nodules of hidradenitis suppurativa with cryotherapy.
Clin Exp Dermatol, 28 (2003), pp. 241-244
[47.]
J.W. Bogers, W. Minderhoud Bassie, F.J. Hiukeshoven.
A case of hidradenitis suppurativa treated with gonadotropin-releasing hormone agonist and by total abdominal hysterectomy with bilateral salpingo-oophorectomy.
Am J Obstet Gynecol, 167 (1992), pp. 517-518
[48.]
C. Camisa, C. Sexton, C. Friedman.
Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression. A case report.
J Reprod Med, 34 (1989), pp. 543-546
[50.]
B.J. Harrison, S. Kumar, G.F. Read, C.A. Edwards, M.F. Scanlon, L.E. Hughes.
Hidradenitis suppurativa: evidence for an endocrine abnormality.
Br J Surg, 72 (1985), pp. 1002-1004
[51.]
R.S. Sawers, V.A. Randall, F.J. Ebling.
Control of hidradenitis suppurativa in women using combined antiandrogen and oestrogen therapy.
Br J Dermatol, 115 (1986), pp. 269-274
[52.]
P.C. Goldsmith, P.M. Dowd.
Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline.
J R Soc Med, 86 (1993), pp. 729-730
[53.]
R.F. Rose, M.J. Goodfield, S.M. Clark.
Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin.
Clin Exp Dermatol, 31 (2006), pp. 154-155
[54.]
N. Usmani, T.H. Clayton, S. Everett, M.D. Goodfield.
Variable response of hidradenitis suppurativa to infliximab in four patients.
Clin Exp Dermatol, 32 (2007), pp. 204-205
[55.]
L. Fardet, A. Dupuy, D. Kerob, A. Levy, M. Allez, E. Begon, et al.
Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
J Am Acad Dermatol, 56 (2007), pp. 624-628
[56.]
B.J. Harrison, M. Mudge, L.E. Hughes.
Recurrence after surgical treatment of hidradenitis suppurativa.
Br Med J (Clin Res Ed), 294 (1987), pp. 487-489
[57.]
R.W. Parks, T.G. Parks.
Pathogenesis, clinical features and management of hidradenitis suppurativa.
Ann R Coll Surg Engl, 79 (1997), pp. 83-89
[58.]
J.P. Ritz, N. Runkel, J. Haier, H.J. Buhr.
Extent of surgery and recurrence rate of hidradenitis suppurativa.
Int J Colorectal Dis, 13 (1998),
[59.]
G.A. Knaysi Jr., B. Cosman, G.F. Crikelair.
Hidradenitis suppurativa.
JAMA, 203 (1968), pp. 19-22
[60.]
A. Tanaka, M. Hatoko, H. Tada, M. Kuwahara, K. Mashiba, S. Yurugi.
Experience with surgical treatment of hidradenitis suppurativa.
Ann Plast Surg, 47 (2001), pp. 636-642
[61.]
H.R. Bailey, M.J. Snyder.
Operative management of hidradenitis suppurativa.
Op Tech Gen Surg, 3 (2001), pp. 117-123
Copyright © 2008. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
